<DOC>
	<DOCNO>NCT01565096</DOCNO>
	<brief_summary>The aim pilot-study investigate effect Vildagliptin comparison glimepiride beta cell function cardiovascular risk profile patient previously treat Metformin monotherapy .</brief_summary>
	<brief_title>Effect Adding Vildagliptin Beta Cell Function Cardiovascular Risk Markers Patients With Moderate Metabolic Control During Metformin Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diabetes mellitus type 2 HbA1c &gt; 6.5 % * ≤ 9.5 % * NOTE : Patients cardiovascular precondition ( Coronary Heart Disease Myocard Infarction ) require HbA1c &gt; 7.0 % ≤ 9.5 % Treatment Metformin maximal maximal tolerate dosage , stable least 3 month indication treatment additional medication judge investigator Age 30 80 year Patient consent his/her family physician inform trial participation Pretreatment insulin , peroxisome proliferator activate receptor ( PPAR ) gamma agonists oral antidiabetic treatment ( except Metformin ) within last three month History type1diabetes Fasting blood glucose &gt; 240mg/dl Uncontrolled hypertension ( systolic blood pressure &gt; 160 and/or diastolic blood pressure &gt; 90 ) Anamnestic history acute infection Anamnestic history epilepsy Anamnestic history hypersensitivity study drug drug similar chemical structure History severe multiple allergy Hereditary galactose intolerance , lapplactase defect glucosegalactose malabsorption Treatment investigational drug within 3 month trial entry Pregnant lactate woman Sexually active woman childbearing age practice highly effective method birth control define result low failure rate ( i.e . le 1 % per year ) use consistently correctly implant , injectables , combine oral contraceptive , hormonal intrauterine device , sexual abstinence vasectomize partner Progressive fatal disease History drug alcohol abuse past 2 year State kidney transplantation Serum potassium &gt; 5.5 mmol/L Acute myocardial infarction , open heart surgery cerebral event ( stroke/transient ischemic attack ) within previous 6 month Any elective surgery study participation Have one unexplained episode severe hypoglycemia ( define require assistance another person due disable hypoglycemia ) within 6 month prior screen visit History pancreatitis Anamnestic history dehydration , diabetic precoma diabetic ketoacidosis Acute schedule investigation iodine contain radiopaque material Uncontrolled unstable angina pectoris Anamnestic history pericarditis , myocarditis , endocarditis , hemodynamic relevant aortic stenosis , aortic aneurysm heart insufficiency NYHA III IV Anamnestic recent pulmonary embolism History significant cardiovascular , respiratory , gastrointestinal , hepatic ( ALAT and/or ASAT &gt; 3 time normal reference range ) , renal ( GFR &lt; 60 ml ) , neurological , psychiatric and/or hematological disease judge investigator Lack compliance similar reason , accord investigator , preclude satisfactory participation study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>